Trial intelligence / Profile preview

Betamethasone Gel vs Lidocaine Jelly for Post-Intubation Symptoms

NCT02114021Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Mar 2012
Primary completion
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of betamethasone dipropionate spray 0.05% and lidocaine 10% oropharyngeal spray in tracheal stenosis (TS) (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Incidence of postoperative sore throat at 24 hours, Incidence of postoperative cough at 24 hours and 1 more. Started Mar 2012; status: completed.

02

Drugs

betamethasone dipropionate spray 0.05%lidocaine 10% oropharyngeal spray
03

Conditions

tracheal stenosis (TS)

Beyond the preview

Go deeper on NCT02114021.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02114021.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call